AstraZeneca second dose doesn’t raise risk of rare blood clots – study

AstraZeneca’s Covid-19 shot did not increase the instances of rare blood clots with low platelets in people after the second dose, a study showed on Wednesday, potentially easing some worries over the vaccine’s side effects.

To continue reading, please click here 

Related Articles

Leave a Reply

Back to top button